• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异位人端粒酶催化亚基表达维持端粒长度,但不足以使CD8 + T淋巴细胞永生化。

Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization.

作者信息

Migliaccio M, Amacker M, Just T, Reichenbach P, Valmori D, Cerottini J C, Romero P, Nabholz M

机构信息

Division of Clinical Oncoimmunology, Ludwig Institute for Cancer Research, University Hospital, Lausanne, Switzerland.

出版信息

J Immunol. 2000 Nov 1;165(9):4978-84. doi: 10.4049/jimmunol.165.9.4978.

DOI:10.4049/jimmunol.165.9.4978
PMID:11046025
Abstract

Like most somatic human cells, T lymphocytes have a limited replicative life span. This phenomenon, called senescence, presents a serious barrier to clinical applications that require large numbers of Ag-specific T cells such as adoptive transfer therapy. Ectopic expression of hTERT, the human catalytic subunit of the enzyme telomerase, permits fibroblasts and endothelial cells to avoid senescence and to become immortal. In an attempt to immortalize normal human CD8(+) T lymphocytes, we infected bulk cultures or clones of these cells with a retrovirus transducing an hTERT cDNA clone. More than 90% of transduced cells expressed the transgene, and the cell populations contained high levels of telomerase activity. Measuring the content of total telomere repeats in individual cells (by flowFISH) we found that ectopic hTERT expression reversed the gradual loss of telomeric DNA observed in control populations during long term culture. Telomere length in transduced cells reached the levels observed in freshly isolated normal CD8(+) lymphocytes. Nevertheless, all hTERT-transduced populations stopped to divide at the same time as nontransduced or vector-transduced control cells. When kept in IL-2 the arrested cells remained alive. Our results indicate that hTERT may be required but is not sufficient to immortalize human T lymphocytes.

摘要

与大多数人体体细胞一样,T淋巴细胞的复制寿命有限。这种被称为衰老的现象,对需要大量抗原特异性T细胞的临床应用(如过继性细胞转移疗法)构成了严重障碍。端粒酶的人类催化亚基hTERT的异位表达,可使成纤维细胞和内皮细胞避免衰老并实现永生化。为了使正常人CD8(+) T淋巴细胞永生化,我们用转导hTERT cDNA克隆的逆转录病毒感染了这些细胞的大量培养物或克隆。超过90%的转导细胞表达了转基因,并且细胞群体具有高水平的端粒酶活性。通过流式荧光原位杂交(flowFISH)测量单个细胞中端粒重复序列的总量,我们发现异位hTERT表达逆转了长期培养过程中对照群体中观察到的端粒DNA的逐渐丢失。转导细胞中的端粒长度达到了新鲜分离的正常CD8(+)淋巴细胞中观察到的水平。然而,所有hTERT转导群体与未转导或载体转导的对照细胞同时停止分裂。当置于白细胞介素-2中时,停滞的细胞仍保持存活。我们的结果表明,hTERT可能是使人类T淋巴细胞永生化所必需的,但并不充分。

相似文献

1
Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8+ T lymphocyte immortalization.异位人端粒酶催化亚基表达维持端粒长度,但不足以使CD8 + T淋巴细胞永生化。
J Immunol. 2000 Nov 1;165(9):4978-84. doi: 10.4049/jimmunol.165.9.4978.
2
Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential.将人类端粒酶逆转录酶(TERT)基因导入T淋巴细胞可导致复制潜能的延长。
Blood. 2001 Aug 1;98(3):597-603. doi: 10.1182/blood.v98.3.597.
3
Immortalization of human CD8+ T cell clones by ectopic expression of telomerase reverse transcriptase.通过端粒酶逆转录酶的异位表达实现人CD8 + T细胞克隆的永生化。
J Immunol. 2000 Oct 15;165(8):4239-45. doi: 10.4049/jimmunol.165.8.4239.
4
Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.大量培养的过表达hTERT的人成纤维细胞在长时间增殖后会遭遇生长危机。
Exp Cell Res. 2000 Sep 15;259(2):336-50. doi: 10.1006/excr.2000.4982.
5
Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization.对HIV特异性CD8 + T细胞中端粒酶进行基因操作:增强的抗病毒功能伴随着增殖潜力的增加和端粒长度的稳定。
J Immunol. 2004 Nov 15;173(10):6303-11. doi: 10.4049/jimmunol.173.10.6303.
6
Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age.随着年龄增长,人类T淋巴细胞和B淋巴细胞中特定谱系的端粒缩短以及端粒酶表达能力未改变。
J Immunol. 2000 Aug 1;165(3):1191-6. doi: 10.4049/jimmunol.165.3.1191.
7
Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.敲低p53并结合端粒酶催化亚基的表达足以使原代人卵巢表面上皮细胞永生化。
Carcinogenesis. 2007 Jan;28(1):174-82. doi: 10.1093/carcin/bgl115. Epub 2006 Jul 8.
8
Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.在过表达hTERT的CD4+ T淋巴细胞中的端粒丢失、衰老和基因不稳定
Blood. 2005 Jul 1;106(1):43-50. doi: 10.1182/blood-2004-10-4144. Epub 2005 Mar 1.
9
Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.在正常人细胞中重建端粒酶活性会导致端粒延长和复制寿命延长。
Curr Biol. 1998 Feb 26;8(5):279-82. doi: 10.1016/s0960-9822(98)70109-5.
10
Telomerase immortalization of human myometrial cells.人子宫肌层细胞的端粒酶永生化
Biol Reprod. 2002 Aug;67(2):506-14. doi: 10.1095/biolreprod67.2.506.

引用本文的文献

1
Engineering resilient CAR T cells for immunosuppressive environment.构建适用于免疫抑制环境的适应性嵌合抗原受体T细胞
Mol Ther. 2025 Jun 4;33(6):2391-2405. doi: 10.1016/j.ymthe.2025.01.035. Epub 2025 Jan 25.
2
Regulation of telomerase towards tumor therapy.端粒酶对肿瘤治疗的调控。
Cell Biosci. 2023 Dec 18;13(1):228. doi: 10.1186/s13578-023-01181-6.
3
Epigenetic strategies to boost CAR T cell therapy.表观遗传学策略增强 CAR T 细胞疗法。
Mol Ther. 2021 Sep 1;29(9):2640-2659. doi: 10.1016/j.ymthe.2021.08.003. Epub 2021 Aug 6.
4
Telomerase activation in the treatment of aging or degenerative diseases: a systematic review.端粒酶激活治疗衰老或退行性疾病:系统评价。
Mol Cell Biochem. 2021 Feb;476(2):599-607. doi: 10.1007/s11010-020-03929-x. Epub 2020 Oct 1.
5
Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward.嵌合抗原受体(CAR)T细胞在过继性癌症免疫治疗中的长期持续存在:挑战与未来方向
Front Immunol. 2020 Apr 22;11:702. doi: 10.3389/fimmu.2020.00702. eCollection 2020.
6
Expression and regulation of telomerase in human T cell differentiation, activation, aging and diseases.端粒酶在人 T 细胞分化、激活、衰老和疾病中的表达和调控。
Cell Immunol. 2019 Nov;345:103989. doi: 10.1016/j.cellimm.2019.103989. Epub 2019 Sep 19.
7
Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA.通过递送修饰的端粒酶逆转录酶(TERT)mRNA增强CD19嵌合抗原受体T细胞在体内的持久性和抗肿瘤功效。
Cell Discov. 2015 Dec 8;1:15040. doi: 10.1038/celldisc.2015.40. eCollection 2015.
8
A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.恶性神经胶质瘤免疫治疗的新希望:过继性 T 细胞转移治疗。
J Immunol Res. 2014;2014:326545. doi: 10.1155/2014/326545. Epub 2014 Jun 9.
9
Functional assessment of pharmacological telomerase activators in human T cells.人类 T 细胞中药理学端粒酶激活剂的功能评估。
Cells. 2013 Jan 14;2(1):57-66. doi: 10.3390/cells2010057.
10
Engineered T cells for cancer treatment.肿瘤治疗用工程化 T 细胞。
Cytotherapy. 2014 Jun;16(6):713-33. doi: 10.1016/j.jcyt.2013.10.002. Epub 2013 Nov 13.